The Big Three Healthcare REITs: WELL, VTR, DOC

Introduction

Welltower has traded at roughly 205% of net asset value and close to 39 times AFFO, multiples that would be absurd for almost any other real estate company. Healthpeak, a healthcare REIT of genuine scale, has traded at a fraction of that. The two own broadly similar buildings, carry similar tenants, and ride the same demographic tailwind, so the gap is not about the assets in the abstract. It is about how much of the senior housing operating business each one chose to own. The three names that dominate listed healthcare real estate, Welltower (WELL), Ventas (VTR), and Healthpeak Properties (DOC), have made very different bets on that single question, and the market has rewarded them accordingly. Understanding the Big Three is mostly an exercise in reading those bets.

All three are diversified across the core healthcare property types, but the weightings differ enough to define them. Welltower is the giant, with a common-equity market capitalization north of $138 billion by late 2025 and more than 2,400 properties, growing rapidly through its 2025 acquisitions, spanning senior housing, outpatient medical, and a smaller life science and innovation sleeve. Ventas is the closest peer in strategy, similarly leaning into senior housing operating exposure while keeping meaningful medical office and life science portfolios. Healthpeak took the opposite path for years, exiting senior housing entirely to concentrate on outpatient medical buildings and laboratory space, before reversing course.

The composition matters because each property type carries a different cash flow profile. The operating-intensity spectrum that defines healthcare real estate runs from net-leased medical office, where rent is contractual, to senior housing operating portfolios, where the REIT owns the building's profit-and-loss directly. A REIT's mix along that spectrum is the single biggest input into how its earnings grow and how the market prices them.

Underneath all three sits the same demographic engine. The number of Americans aged 80 and older, the core senior housing customer, is set to grow sharply through the 2030s as the baby boomers age in, while construction of new senior housing fell to multi-decade lows after the pandemic. That collision of accelerating demand and constrained new supply is what turned the senior housing recovery into a multi-year occupancy and rate cycle rather than a one-year bounce, and it is the reason Welltower's and Ventas's operating bets have paid off so dramatically. The same wave supports demand for the medical office and outpatient space Healthpeak owns, though through steady utilization rather than the operating-leverage spike that operating senior housing portfolios capture.

Seniors Housing Operating Portfolio (SHOP)

A structure, enabled by the RIDEA rules, in which a healthcare REIT owns both the senior housing real estate and the operating business run by a third-party manager, so it collects the community's net operating income directly rather than a fixed rent. SHOP gives the REIT the full upside of rising occupancy and rates and the full downside of wage and cost inflation, which is why it is the highest-beta exposure in healthcare real estate.

Welltower's valuation is a direct function of a deliberate transformation. Operating senior housing provided about 70% of its NOI by the end of 2025, up from roughly 31% at the end of 2021. Much of that shift came from converting net-leased communities into operating structures the REIT controls, so Welltower now captures resident-fee growth directly instead of collecting a flat rent while the operator keeps the upside. That shift coincided with the senior housing recovery, and the results have been extraordinary: same-store NOI in the Seniors Housing Operating portfolio grew 20.4% in the fourth quarter of 2025, the thirteenth consecutive quarter of 20%-plus growth, while total same-store NOI rose 15.0%. Normalized FFO reached $5.29 per share for 2025, up 22.5% year over year, and management lifted its 2026 outlook on the back of continued senior housing strength.

The risk in that story is the price. Trading at roughly 205% of NAV and 39 times AFFO prices in years of continued execution, and the same operating leverage that drives growth on the way up reverses on the way down. The market is paying a hero-worship multiple for a senior housing recovery that is real but cyclical.

Ventas has run a close parallel to Welltower, leaning into senior housing operating exposure while keeping a more diversified base across medical office and life science. The payoff has been strong if less spectacular: its SHOP same-store NOI grew 15.4% from the fourth quarter of 2024 to the fourth quarter of 2025, total shareholder return topped 35% for 2025, and Normalized FFO per share rose about 9% to $3.48. Ventas is, in effect, the same trade as Welltower expressed with a slightly steadier hand and a lower multiple, which makes it the more conservative way to own the senior housing recovery. Its larger medical office and life science footprint dilutes the senior housing growth but also cushions the downside, so an investor who finds Welltower's premium too rich often lands on Ventas as the next-best expression of the identical demographic thesis.

Healthpeak is the instructive contrast. By concentrating on outpatient medical and laboratory space, it traded the senior housing upside for the defensiveness of those sub-types, only to watch life science turn into a drag. The life sciences downturn that battered Alexandria hit Healthpeak's lab segment for the same reasons: demand tied to biotech funding fell sharply, oversupply in the major research markets had nowhere to go, and vacancy rose while rents declined. A bet meant to be defensive turned cyclical at the worst time. The strategic lesson landed publicly when Healthpeak announced Janus Living, a spin-off of a dedicated senior housing vehicle launching with 34 communities and a pipeline of roughly $675 million of investments under signed agreements. A REIT that had deliberately exited senior housing decided the operating opportunity was too large to keep ignoring, a reversal documented in the recent wave of healthcare REIT M&A.

Healthpeak's other defining move was scale in the defensive segment it kept. In a roughly $21 billion all-stock merger of equals that closed in March 2024, it combined with Physicians Realty Trust, a pure outpatient medical REIT, and adopted the new ticker DOC. The deal made the combined company one of the largest owners of outpatient medical buildings in the country and leaned further into the contractual, recession-resistant income that medical office throws off, even as the Janus spin-off carried it back toward senior housing operating upside. The two moves together reframe Healthpeak as a barbell: a deep, stable medical-office base on one end and a renewed senior housing option on the other.

The cleanest way to read the Big Three is to stop treating the valuation spread as a verdict on management quality and start treating it as a measure of operating exposure. The market is paying up for senior housing operating NOI because that income is compounding at rates no net lease can match, and discounting lab and net-leased exposure because that income is either flat or falling. Welltower sits at the high-beta end and earns the premium and the risk; Healthpeak sat at the defensive end and got punished when its defensive bet (lab) went wrong; Ventas sits in between.

Premium or discount to NAV

A REIT's market value compared to the appraised net asset value of its properties less debt. A premium (trading above NAV) signals the market expects the company to grow value faster than its current portfolio implies, often through development or operating upside; a discount signals the opposite. Welltower's roughly 205% of NAV is among the most extreme premiums in the REIT universe.

What ultimately separates the three is not size or growth rate but operating exposure, and the market prices that one variable with conviction. Welltower's roughly 70% SHOP NOI and its compounding growth are why it earns its premium; that same operating intensity is why the premium is also its chief risk, because a stall in senior housing fundamentals would hit it harder than any leased-asset peer. How much of the operating result each REIT keeps rather than leases away drives both the divergence in their growth and how each trades against its net asset value and on FFO and AFFO multiples. Read the Big Three as three positions on operating intensity rather than one defensive trade on aging demographics, and the otherwise puzzling valuation gaps resolve into a single coherent picture.